Patents Assigned to GLYKOS BIOMEDICAL OY
  • CONJUGATE
    Publication number: 20210402002
    Abstract: A conjugate is disclosed. The conjugate may comprise a targeting unit for delivery to a tumour, and a glycosylation inhibitor for inhibiting glycosylation in the tumour, thereby decreasing the immunosuppressive activity of the tumour. The glycosylation inhibitor may be conjugated to the targeting unit.
    Type: Application
    Filed: June 19, 2019
    Publication date: December 30, 2021
    Applicant: GLYKOS BIOMEDICAL OY
    Inventors: Juhani SAARINEN, Tero SATOMAA, Olli AITIO
  • CONJUGATES
    Publication number: 20210138080
    Abstract: A conjugate is disclosed. The conjugate may comprise a targeting unit for delivery to a target tissue, and a Galectin inhibitor for inhibiting Galectin interaction within the target tissue, wherein the Galectin inhibitor is conjugated to the targeting unit.
    Type: Application
    Filed: June 19, 2019
    Publication date: May 13, 2021
    Applicant: GLYKOS BIOMEDICAL OY
    Inventors: Tero SATOMAA, Juhani SAARINEN